
Big Pharma’s Gold Rush: The Battle for Weight Loss Medications Heats Up
Sanofi leads pharmaceutical innovation by merging advanced technology with strategic healthcare approaches. GLP-1 medications emerge as groundbreaking for weight loss and treating conditions like addiction and Alzheimer’s. Industry potential grows with strategic acquisitions, exemplified by Roche acquiring Carmot Therapeutics. Despite a 48.6%